These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31661659)

  • 1. Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers.
    Peitzmeier SM; Bernstein IM; McDowell MJ; Pardee DJ; Agénor M; Alizaga NM; Reisner SL; Potter J
    Cult Health Sex; 2020 Dec; 22(12):1315-1332. PubMed ID: 31661659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives.
    Agénor M; Peitzmeier SM; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
    Cult Health Sex; 2016 Oct; 18(10):1192-206. PubMed ID: 27142466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "It Can Promote an Existential Crisis": Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals.
    Peitzmeier SM; Agénor M; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
    Qual Health Res; 2017 Dec; 27(14):2138-2149. PubMed ID: 28836483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecologic Health Care Providers' Willingness to Provide Routine Care and Papanicolaou Tests for Transmasculine Individuals.
    Shires DA; Prieto L; Woodford MR; Jaffee KD; Stroumsa D
    J Womens Health (Larchmt); 2019 Nov; 28(11):1487-1492. PubMed ID: 31411513
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
    Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
    LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Literature Review of Cervical Cancer Screening in Transgender Men.
    Gatos KC
    Nurs Womens Health; 2018 Feb; 22(1):52-62. PubMed ID: 29433700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
    Berzansky I; Reynolds CA; Charlton BM
    Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
    PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Health Provider Perspectives Regarding Barriers American Indian/Alaska Native Transgender and Two-Spirit Youth Face Accessing Healthcare.
    Angelino A; Evans-Campbell T; Duran B
    J Racial Ethn Health Disparities; 2020 Aug; 7(4):630-642. PubMed ID: 31933174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults.
    Agénor M; White Hughto JM; Peitzmeier SM; Potter J; Deutsch MB; Pardee DJ; Reisner SL
    J Gen Intern Med; 2018 Jul; 33(7):1015-1017. PubMed ID: 29654599
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
    BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgender and non-binary peoples experiences of cervical cancer screening: A scoping review.
    Rivers G; Hinchliff S; Thompson J
    J Clin Nurs; 2024 Jun; 33(6):2112-2122. PubMed ID: 38334194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening.
    Peitzmeier SM; Reisner SL; Harigopal P; Potter J
    J Gen Intern Med; 2014 May; 29(5):778-84. PubMed ID: 24424775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences and Challenges of African American and Sub-Saharan African Immigrant Black Women in Completing Pap Screening: a Mixed Methods Study.
    Adebola A; Adaeze A; Adeyimika D; Lovoria WB; Gia MM
    J Racial Ethn Health Disparities; 2024 Jun; 11(3):1405-1417. PubMed ID: 37129785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Gender-Affirming Provider Communication to Increase Health Care Access and Utilization Among Transgender Men and Trans-Masculine Non-Binary Individuals.
    Klein A; Golub SA
    LGBT Health; 2020; 7(6):292-304. PubMed ID: 32493100
    [No Abstract]   [Full Text] [Related]  

  • 17. Transition from Pediatric to Adult Care for Transgender Youth: A Qualitative Study of Patient, Parent, and Provider Perspectives.
    Pham T; García A; Tsai M; Lau M; Kuper LE
    LGBT Health; 2021; 8(4):281-289. PubMed ID: 33835876
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender Identity Disparities in Cancer Screening Behaviors.
    Tabaac AR; Sutter ME; Wall CSJ; Baker KE
    Am J Prev Med; 2018 Mar; 54(3):385-393. PubMed ID: 29338956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
    Roznovjak D; Petroll AE; Lakatos AEB; Narayan R; Cortina CS
    JCO Oncol Pract; 2023 May; 19(5):e794-e800. PubMed ID: 36800556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical history of female-to-male transgender patients is needed to avoid misinterpretation of cervical Papanicolaou tests.
    Moatamed NA; Barco AD; Yang SE; Ying Y; Zhang S; Rodriguez EF
    Cytopathology; 2023 Mar; 34(2):120-129. PubMed ID: 36522845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.